Source comparison
IGF-1 LR3 vs Ipamorelin: Research Comparison
The table below distills the key differentiators that determine peptide selection in experimental design. Every research protocol should map its hypothesis to the mechanism column before selecting a compound. Primary Mechanism Direct IGF-1 receptor agonist in
This comparison does not assign a generated winner or score.
- The table below distills the key differentiators that determine peptide selection in experimental design. Every research protocol should map its hypothesis to the mechanism column before selecting a compound.
- Primary Mechanism
- Direct IGF-1 receptor agonist in peripheral tissues
- Selective GHSR-1a agonist; stimulates pulsatile GH release from pituitary
- IGF-1 LR3 bypasses pituitary; Ipamorelin requires intact GH axis
- Half-Life
- 20–30 hours (sustained receptor activation)
- ~2 hours (discrete GH pulse)
- Dosing frequency and experimental timing differ fundamentally
- Typical Dosing Frequency
- Once daily or alternate day
- 2–3 times daily (aligned with circadian GH windows)
- IGF-1 LR3 suits single-dose protocols; Ipamorelin fits pulsatility studies
- IGF-1 Elevation Pattern
- Immediate, exogenous, sustained 24+ hours
- Delayed, endogenous (via hepatic synthesis), returns to baseline in 3–4 hours
- IGF-1 LR3 = continuous signal; Ipamorelin = physiological pulse
- Binding Protein Interaction
- Reduced IGFBP affinity (increased free fraction)
- Endogenous IGF-1 fully bound by IGFBPs
- Free vs bound IGF-1 affects tissue penetration and systemic distribution
- Receptor Selectivity
- IGF-1R only
- GHSR-1a only (no cortisol, prolactin, or insulin release)
- Both highly selective within their target pathways
- Ideal Research Application
- Direct anabolism, satellite cell proliferation, localized tissue repair, in vitro IGF signaling
- Pituitary function, GH pulsatility, circadian studies, body composition models
- Match mechanism to hypothesis. Not interchangeable
- Storage Post-Reconstitution
- Stable 2–8°C for 28 days; tolerates brief ambient exposure
- Degrades rapidly above 8°C; strict cold chain required
- IGF-1 LR3 more forgiving in multi-day protocols